RU2013112956A - Способ предупреждения преждевременных родов - Google Patents
Способ предупреждения преждевременных родов Download PDFInfo
- Publication number
- RU2013112956A RU2013112956A RU2013112956/15A RU2013112956A RU2013112956A RU 2013112956 A RU2013112956 A RU 2013112956A RU 2013112956/15 A RU2013112956/15 A RU 2013112956/15A RU 2013112956 A RU2013112956 A RU 2013112956A RU 2013112956 A RU2013112956 A RU 2013112956A
- Authority
- RU
- Russia
- Prior art keywords
- relaxin
- administered
- trimester
- pregnancy
- beginning
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title 1
- 230000003449 preventive effect Effects 0.000 title 1
- 102000003743 Relaxin Human genes 0.000 claims abstract 10
- 108090000103 Relaxin Proteins 0.000 claims abstract 10
- 230000035935 pregnancy Effects 0.000 claims abstract 7
- 210000003756 cervix mucus Anatomy 0.000 claims abstract 4
- 206010046901 vaginal discharge Diseases 0.000 claims abstract 4
- 206010000087 Abdominal pain upper Diseases 0.000 claims abstract 2
- 101001091088 Homo sapiens Prorelaxin H2 Proteins 0.000 claims abstract 2
- 208000008930 Low Back Pain Diseases 0.000 claims abstract 2
- 208000005107 Premature Birth Diseases 0.000 claims abstract 2
- 206010036590 Premature baby Diseases 0.000 claims abstract 2
- 102100034949 Prorelaxin H2 Human genes 0.000 claims abstract 2
- 206010046788 Uterine haemorrhage Diseases 0.000 claims abstract 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 claims abstract 2
- 210000001015 abdomen Anatomy 0.000 claims abstract 2
- 230000037396 body weight Effects 0.000 claims abstract 2
- 230000008602 contraction Effects 0.000 claims abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 claims abstract 2
- 208000024891 symptom Diseases 0.000 claims abstract 2
- 210000001742 aqueous humor Anatomy 0.000 claims 1
- 239000007788 liquid Substances 0.000 abstract 1
- 210000004197 pelvis Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2221—Relaxins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
1. Способ повышения массы новорожденных, включающий:а) выбор беременной женщины с риском преждевременных родов, иб) введение фармацевтического состава, включающего фармацевтически активный релаксин Н2,причем релаксин повышает массу новорожденного путем удлинения срока беременности.2. Способ по п. 1, в котором беременная женщина испытывает симптомы, выбранные из группы, состоящей из ранних схваток, спазмов в нижней части живота, тупой боли в пояснице, давления в тазовой области, спазмов желудка, выделений из влагалища, влагалищных кровотечений и влагалищных выделений водянистой жидкости.3. Способ по п. 1, в котором релаксин вводят в количестве при диапазоне величин примерно от 0,1 до 500 мкг/кг массы тела субъекта.4. Способ по п. 1, в котором релаксин вводят в начале первого триместра беременности.5. Способ по п. 1, в котором релаксин вводят в начале второго триместра беременности.6. Способ по п. 1, в котором релаксин вводят в начале третьего триместра беременности.
Claims (6)
1. Способ повышения массы новорожденных, включающий:
а) выбор беременной женщины с риском преждевременных родов, и
б) введение фармацевтического состава, включающего фармацевтически активный релаксин Н2,
причем релаксин повышает массу новорожденного путем удлинения срока беременности.
2. Способ по п. 1, в котором беременная женщина испытывает симптомы, выбранные из группы, состоящей из ранних схваток, спазмов в нижней части живота, тупой боли в пояснице, давления в тазовой области, спазмов желудка, выделений из влагалища, влагалищных кровотечений и влагалищных выделений водянистой жидкости.
3. Способ по п. 1, в котором релаксин вводят в количестве при диапазоне величин примерно от 0,1 до 500 мкг/кг массы тела субъекта.
4. Способ по п. 1, в котором релаксин вводят в начале первого триместра беременности.
5. Способ по п. 1, в котором релаксин вводят в начале второго триместра беременности.
6. Способ по п. 1, в котором релаксин вводят в начале третьего триместра беременности.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12788808P | 2008-05-16 | 2008-05-16 | |
| US61/127,888 | 2008-05-16 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010151471/14A Division RU2501573C2 (ru) | 2008-05-16 | 2009-05-15 | Способ предупреждения преждевременных родов |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013112956A true RU2013112956A (ru) | 2014-09-27 |
Family
ID=41319085
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010151471/14A RU2501573C2 (ru) | 2008-05-16 | 2009-05-15 | Способ предупреждения преждевременных родов |
| RU2013112956/15A RU2013112956A (ru) | 2008-05-16 | 2013-03-22 | Способ предупреждения преждевременных родов |
| RU2013112954/15A RU2013112954A (ru) | 2008-05-16 | 2013-03-22 | Способ предупреждения преждевременных родов |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010151471/14A RU2501573C2 (ru) | 2008-05-16 | 2009-05-15 | Способ предупреждения преждевременных родов |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013112954/15A RU2013112954A (ru) | 2008-05-16 | 2013-03-22 | Способ предупреждения преждевременных родов |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20110166070A1 (ru) |
| EP (1) | EP2288367B1 (ru) |
| JP (2) | JP5653346B2 (ru) |
| CN (1) | CN102026650A (ru) |
| AU (1) | AU2009246116B2 (ru) |
| BR (1) | BRPI0912653A2 (ru) |
| CA (1) | CA2724542A1 (ru) |
| ES (1) | ES2559107T3 (ru) |
| MX (1) | MX2010012448A (ru) |
| PT (1) | PT2288367E (ru) |
| RU (3) | RU2501573C2 (ru) |
| WO (1) | WO2009140661A1 (ru) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9797903B2 (en) | 2012-10-24 | 2017-10-24 | Winthrop-University Hospital | Non-invasive biomarker to identify subject at risk of preterm delivery |
| EP4011919A3 (en) | 2015-12-09 | 2022-10-12 | The Scripps Research Institute | Relaxin immunoglobulin fusion proteins and methods of use |
| US20200264188A1 (en) | 2017-09-13 | 2020-08-20 | Progenity, Inc. | Preeclampsia biomarkers and related systems and methods |
| EP4070113A4 (en) | 2019-12-04 | 2023-12-20 | Biora Therapeutics, Inc. | ASSESSMENT OF PREECAMPSIA USING FREE AND DISSOCIATE PLACENTAL GROWTH FACTOR ASSAYS |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2852431A (en) * | 1954-05-17 | 1958-09-16 | Warner Lambert Pharmaceutical | Process for the extraction and purification of relaxin using trichloracetic acid |
| US3003917A (en) * | 1959-01-14 | 1961-10-10 | Nat Drug Co | Wound healing composition |
| NZ206534A (en) * | 1982-12-13 | 1988-05-30 | Florey Howard Inst | Molecular cloning and characterisation of gene sequence coding for human relaxin |
| WO1989007945A1 (en) * | 1988-02-26 | 1989-09-08 | Genentech, Inc. | Human relaxin formulation |
| IT215259Z2 (it) * | 1988-08-08 | 1990-09-11 | Marianna Calogero | Protesi espansibile per correzioni delle miodistrofie. |
| US5192743A (en) * | 1992-01-16 | 1993-03-09 | Genentech, Inc. | Reconstitutable lyophilized protein formulation |
| IL107167A (en) * | 1993-10-03 | 2000-01-31 | Raziel Lurie | Compositions containing relaxin for treatment of alopecia and related conditions |
| US5545616A (en) * | 1994-09-22 | 1996-08-13 | Genentech, Inc. | Method for predicting and/or preventing preterm labor |
| CA2229479C (en) * | 1995-08-15 | 2010-03-30 | Connective Therapeutics, Inc. | Method of promoting angiogenesis |
| US5612051A (en) * | 1995-11-17 | 1997-03-18 | Yue; Samuel K. | Method of treating involuntary muscle dysfunction with relaxin hormone |
| US6176854B1 (en) * | 1997-10-08 | 2001-01-23 | Robert Roy Cone | Percutaneous laser treatment |
| US20020031513A1 (en) * | 1997-11-24 | 2002-03-14 | Shamir Leibovitz | Method and pharmaceutical composition for inhibiting premature rapture of fetal membranes, ripening of uterine cervix and preterm labor in mammals |
| RU2177789C2 (ru) * | 1999-11-19 | 2002-01-10 | Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия LTD" | Средство, способствующее созреванию шейки матки, способ ускорения созревания шейки матки и устройство для доставки лекарственного средства к шейке матки |
| US20040136949A1 (en) * | 2001-04-24 | 2004-07-15 | Matthias Grell | Combination therapy using anti-angiogenic agents and tnf alpha |
| US20040157771A1 (en) * | 2002-02-28 | 2004-08-12 | Bird Timothy A. | Rank-ligand-induced sodium/proton antiporter polypeptides |
| CA2563433C (en) * | 2004-04-30 | 2010-07-13 | Bas Medical, Inc. | Methods and compositions for control of fetal growth via modulation of relaxin |
| US20060052304A1 (en) * | 2004-09-02 | 2006-03-09 | Bas Medical, Inc. | Method for remodeling bone and related sutures |
-
2009
- 2009-05-15 EP EP09747742.6A patent/EP2288367B1/en not_active Not-in-force
- 2009-05-15 ES ES09747742.6T patent/ES2559107T3/es active Active
- 2009-05-15 MX MX2010012448A patent/MX2010012448A/es not_active Application Discontinuation
- 2009-05-15 RU RU2010151471/14A patent/RU2501573C2/ru not_active IP Right Cessation
- 2009-05-15 PT PT97477426T patent/PT2288367E/pt unknown
- 2009-05-15 JP JP2011509784A patent/JP5653346B2/ja not_active Expired - Fee Related
- 2009-05-15 CN CN2009801177561A patent/CN102026650A/zh active Pending
- 2009-05-15 US US12/992,384 patent/US20110166070A1/en not_active Abandoned
- 2009-05-15 CA CA2724542A patent/CA2724542A1/en not_active Abandoned
- 2009-05-15 WO PCT/US2009/044251 patent/WO2009140661A1/en not_active Ceased
- 2009-05-15 BR BRPI0912653A patent/BRPI0912653A2/pt not_active IP Right Cessation
- 2009-05-15 AU AU2009246116A patent/AU2009246116B2/en not_active Ceased
-
2013
- 2013-03-22 RU RU2013112956/15A patent/RU2013112956A/ru not_active Application Discontinuation
- 2013-03-22 RU RU2013112954/15A patent/RU2013112954A/ru not_active Application Discontinuation
-
2014
- 2014-06-25 JP JP2014130163A patent/JP2014221783A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| RU2501573C2 (ru) | 2013-12-20 |
| AU2009246116A1 (en) | 2009-11-19 |
| CN102026650A (zh) | 2011-04-20 |
| BRPI0912653A2 (pt) | 2019-09-24 |
| EP2288367A1 (en) | 2011-03-02 |
| EP2288367A4 (en) | 2013-06-26 |
| ES2559107T3 (es) | 2016-02-10 |
| US20110166070A1 (en) | 2011-07-07 |
| CA2724542A1 (en) | 2009-11-19 |
| PT2288367E (pt) | 2016-02-09 |
| EP2288367B1 (en) | 2015-10-07 |
| JP2014221783A (ja) | 2014-11-27 |
| RU2013112954A (ru) | 2014-09-27 |
| WO2009140661A1 (en) | 2009-11-19 |
| MX2010012448A (es) | 2011-03-25 |
| AU2009246116B2 (en) | 2013-02-14 |
| JP2011520919A (ja) | 2011-07-21 |
| RU2010151471A (ru) | 2012-06-27 |
| JP5653346B2 (ja) | 2015-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2017203991B2 (en) | Use of estetrol as emergency contraceptive | |
| Friederich | Dysmenorrhea | |
| JP2016175943A (ja) | 子宮内膜症又は腺筋症に伴う症状を治療するための薬剤調合におけるウリプリスタル又は任意のウリプリスタル代謝物の治療効果のある量の使用方法 | |
| RU2013112956A (ru) | Способ предупреждения преждевременных родов | |
| Vilos | Laparoscopic resection of a heterotopic cornual pregnancy followed by term vaginal delivery | |
| ABRAHAM | Primary dysmenorrhea | |
| Kozinszky et al. | Ectopic pregnancy after levonorgestrel emergency contraception | |
| Holdcroft | Postpartum lower abdominal pain | |
| Stys | Endocrine regulation of cervical functions during pregnancy and labor | |
| Abasiattai et al. | Spontaneous heterotrophic pregnancy with tubal rupture and delivery of a live baby at term: A case report | |
| Serrano et al. | Normal Labour | |
| RU2682167C1 (ru) | Способ профилактики преэклампсии | |
| RU2578476C1 (ru) | Способ лечения угрожающих преждевременных родов | |
| Bermejo et al. | Physiology Related to Sex of Pregnancy As | |
| Whang et al. | Ectopic pregnancy occurring in the remnant tube of a previous adnexectomy: a case report | |
| KESANI | COMPARATIVE STUDY OF 25 μg INTRAVAGINAL MISOPROSTOL AND 0.5 mg INTRACERVICAL DINOPROSTONE FOR INDUCTION OF LABOUR | |
| Sturlese et al. | Heterotopic pregnancy: case report | |
| 陈蔚琳 et al. | Contraceptive vaginal ring (NuvaRing)-a novel, convenient and effective contraceptive option | |
| Terzić et al. | Acute abdomen caused by adnexal torsion in the first trimester of pregnancy: a case report | |
| Doshi | Thyroid Disorders in Pregnancy | |
| RU2452481C1 (ru) | Способ лечения больных с привычным невынашиванием беременности в первом триместре | |
| MOLE | Iº THE EToLoGY of preeclampsia-eclampsia | |
| RU2440815C1 (ru) | Способ профилактики тяжелого гестоза | |
| Iyengar | Clinical Comparative Study of Postpartum Blood Loss Following Labor Induction with Misoprostol Versus Induction with Dinoprostone Using Specialized Blood Collection Bag at BMCRI | |
| Madhini et al. | BONAFIDE CERTIFICATE |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20170912 |